Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission. - Yu, Shuling; Zhuang, Wanchuan; Gao, Shengfa; Li, Tongyu; Yan, Xiao; Ouyang, Guifang; Zhang, Ping (Cancer Medicine, 2025)